16-68245529-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_012320.4(PLA2G15):​c.103G>A​(p.Gly35Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000022 in 1,590,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

PLA2G15
NM_012320.4 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.286
Variant links:
Genes affected
PLA2G15 (HGNC:17163): (phospholipase A2 group XV) Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene hydrolyzes lysophosphatidylcholine to glycerophosphorylcholine and a free fatty acid. This enzyme is present in the plasma and thought to be associated with high-density lipoprotein. A later paper contradicts the function of this gene. It demonstrates that this gene encodes a lysosomal enzyme instead of a lysophospholipase and has both calcium-independent phospholipase A2 and transacylase activities. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.043177366).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLA2G15NM_012320.4 linkuse as main transcriptc.103G>A p.Gly35Arg missense_variant 1/6 ENST00000219345.10 NP_036452.1 Q8NCC3-1
PLA2G15NM_001363551.2 linkuse as main transcriptc.103G>A p.Gly35Arg missense_variant 1/6 NP_001350480.1
PLA2G15XM_011522979.3 linkuse as main transcriptc.103G>A p.Gly35Arg missense_variant 1/7 XP_011521281.1
PLA2G15XM_011522980.4 linkuse as main transcriptc.103G>A p.Gly35Arg missense_variant 1/7 XP_011521282.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLA2G15ENST00000219345.10 linkuse as main transcriptc.103G>A p.Gly35Arg missense_variant 1/61 NM_012320.4 ENSP00000219345.5 Q8NCC3-1

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152108
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000381
AC:
8
AN:
210124
Hom.:
0
AF XY:
0.0000435
AC XY:
5
AN XY:
114834
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000157
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000105
Gnomad OTH exome
AF:
0.000374
GnomAD4 exome
AF:
0.0000146
AC:
21
AN:
1438096
Hom.:
0
Cov.:
31
AF XY:
0.0000168
AC XY:
12
AN XY:
714852
show subpopulations
Gnomad4 AFR exome
AF:
0.0000304
Gnomad4 AMR exome
AF:
0.000303
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.05e-7
Gnomad4 OTH exome
AF:
0.000101
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152108
Hom.:
0
Cov.:
32
AF XY:
0.0000942
AC XY:
7
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000916
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000355
ExAC
AF:
0.00000829
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 03, 2022The c.103G>A (p.G35R) alteration is located in exon 1 (coding exon 1) of the PLA2G15 gene. This alteration results from a G to A substitution at nucleotide position 103, causing the glycine (G) at amino acid position 35 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Uncertain
0.045
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
15
DANN
Benign
0.87
DEOGEN2
Benign
0.0094
.;T;T;T;.;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0047
N
LIST_S2
Benign
0.61
T;T;T;T;T;T;T
M_CAP
Benign
0.081
D
MetaRNN
Benign
0.043
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Benign
0.0
N;.;N;.;.;.;.
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.13
N;N;N;N;N;N;N
REVEL
Benign
0.26
Sift
Pathogenic
0.0
D;T;T;T;T;D;T
Sift4G
Uncertain
0.030
D;T;T;T;T;D;T
Polyphen
0.0010, 0.0020, 0.0080
.;.;B;.;B;B;.
Vest4
0.32
MutPred
0.35
Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);Loss of relative solvent accessibility (P = 0.0404);
MVP
0.17
MPC
1.3
ClinPred
0.053
T
GERP RS
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771226585; hg19: chr16-68279432; API